• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Brookdale Senior Living Inc.

    7/1/25 4:16:46 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care
    Get the next $BKD alert in real time by email
    DEFA14A 1 pressreleasejuly1.htm DEFA14A Document


     
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549
     
    SCHEDULE 14A

    (Rule 14a-101)

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934
     
    Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐ Preliminary Proxy Statement
    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) 
    ☐ Definitive Proxy Statement
    ☒ Definitive Additional Materials
    ☐ Soliciting Material Pursuant to §240.14a-12

    Brookdale Senior Living Inc.

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

    ☒ No fee required.
    ☐ Fee paid previously with preliminary materials.
    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
     
     





    Below is the Company’s press release published on July 1, 2025, which was also posted on the Company’s website VoteBrookdaleBlue.com, in connection with its 2025 Annual Meeting of Stockholders, which will be held on July 11, 2025:


    image_0.jpg
    Glass Lewis Joins ISS in Raising Concerns About Ortelius’ Campaign at Brookdale

    Proxy Advisory Firms Recommend Against Giving Ortelius Control of the Company’s Board

    Brookdale Urges Shareholders to Vote “FOR” ALL of Brookdale’s Eight Highly Qualified Director Nominees on the BLUE Proxy Card

    NASHVILLE, Tenn., July 1, 2025 – Brookdale Senior Living Inc. (NYSE: BKD) (“Brookdale” or the “Company”) today announced that proxy advisory firm Glass, Lewis & Co., LLC (“Glass Lewis”) has joined proxy advisory firm Institutional Shareholder Services (“ISS”) in recommending that Brookdale shareholders not give control of the Company’s Board of Directors to Ortelius Advisors, L.P. (“Ortelius”), who beneficially owns just 1% of Brookdale’s shares. The Company urges shareholders to vote “FOR” ALL eight of Brookdale’s director nominees at its 2025 Annual Meeting of Shareholders (“Annual Meeting”), scheduled to be held on July 11, 2025.

    In its report, Glass Lewis recognized Ortelius’ poor record of engagement with the Brookdale Board and lack of knowledge about Brookdale’s operations and noted that Ortelius has not provided investors with necessary details about its plans for the Company:

    •“…we are concerned that Ortelius appears to have launched the current campaign without undertaking any substantive board-level engagement. This would be a relatively atypical tack in any case, though we would suggest it draws greater scrutiny in a campaign contemplating majority board turnover. Viewed collectively, we are concerned that the foregoing framework discards the observed near-term yield on Brookdale’s existing efforts while offering investors comparatively poor visibility and functionally vacant benchmarking. We believe this contrasts poorly with an effort to secure six of eight seats on a board...”1

    •“…the Dissident does not, in our view, offer investors a clear, persuasive and measurable framework for execution (e.g. procedural architecture, anticipated timeframes, valuation breakdown). As a parallel concern, our engagement with Brookdale indicated that, despite seeking to flip six board seats and divest a meaningful portion of the Company’s assets, Ortelius had not visited any of the Company’s communities. We are concerned these factors suggests there is substantially no codified standard by which investors would be positioned to hold Ortelius’ nominees accountable, nor is there any indication the Dissident is
    1 Glass Lewis Report issued on June 27, 2025.
    2




    substantively familiar with Brookdale’s owned properties (and thus the values which might be attributable to such properties in a sale process).”1

    ISS had previously noted that “…the dissident has not provided shareholders with a means to assess performance if it gains control of the board”.2

    Further, ISS had noted that “…the dissident does not provide enough details for shareholders to fully assess the plan's feasibility or track execution”.2

    The Brookdale Board additionally commented on the reports issued by the proxy advisory firms, stating:

    While we agree with Glass Lewis and ISS that Ortelius should not have control of the Brookdale Board, we strongly disagree with the proxy advisory firms’ suggestion that the Ortelius campaign for board representation warrants a vote for any one of the Ortelius nominees. The skills offered by Ortelius’ candidates are not additive or relevant to our business.

    Our Board’s slate is uniquely suited to oversee the Company’s business and management team, with complementary skills, insights, and perspectives that are imperative to Brookdale’s operating strategy, real estate portfolio, and regulatory relationships. Our Board composition reflects a thoughtful refreshment process, which allows the Board to benefit from fresh perspectives offered by new directors as well as the institutional knowledge imparted by more tenured members of the Board. If shareholders follow the proxy advisory firms’ recommendation, and Mr. Wielansky and Ms. Freed are removed from the Brookdale Board and any two of Ortelius’ nominees are added, six of Brookdale’s eight directors would have served on the Board for approximately one year or less – putting the Company at risk with minimal institutional experience at the Board level.

    Mr. Wielansky and Ms. Freed bring significant institutional knowledge and offer skillsets and expertise that are required for effective oversight of Brookdale’s strategy. Over the course of Mr. Wielansky’s tenure on the Board, including in his prior role as Non-Executive Chairman of the Board and current role as Chair of the Board’s Investment Committee, we have made substantial progress on optimizing our real estate portfolio – efforts which were recognized by Glass Lewis, writing: “…Brookdale appears to be making earnest efforts to trim underperforming lease assets”.1 Ms. Freed offers unique and highly valuable expertise in sales, revenue management, customer service, and marketing. Her marketing acumen is essential to Brookdale’s business, which stands at the intersection of real estate, healthcare, and hospitality and relies heavily on attracting older adults with our high quality service offering.

    The Brookdale Board also commented on the recommendation issued by Egan-Jones Proxy Services (“Egan-Jones”):

    We believe that Egan-Jones reached the wrong conclusion in failing to recommend that Brookdale shareholders elect all of the Board’s highly qualified director nominees based on Egan-Jones’ understanding of “how each side plans to delever the company”.3 The difference is simple: Brookdale’s strategy to delever and create shareholder value is working, whereas Ortelius’ strategy appears to be vague and untested. Brookdale has in fact already met a key
    2 ISS Report issued on June 18, 2025.
    3 Egan-Jones Report issued on June 30, 2025.
    3




    hurdle cited by Egan-Jones, reporting 80% same community weighted average occupancy (a key turning point towards positive cash flow generation) in Q1 2025. As such, a vote against the Board at this critical juncture is not in the best interests of shareholders.

    The Brookdale Board is highly qualified, refreshed, and overseeing the Company’s continuing growth and transformation with a strategy that is delivering measurable results. The Brookdale Board believes that electing any of the nominees from Ortelius would risk compromising the continued successful execution of the Company’s strategy and impairing its CEO search, ultimately diminishing returns for shareholders.

    The Brookdale Board strongly urges shareholders to vote “FOR” ALL of Brookdale’s eight nominees on the BLUE proxy card to protect the value of your investment.

    Brookdale reminds all shareholders that every vote is important, no matter how many or few shares you own. Please simply disregard any white proxy card you may receive from Ortelius.

    The Annual Meeting is fast approaching. Whether or not you expect to attend, we urge you to follow the easy instructions on your BLUE proxy card or BLUE voting instruction form to vote electronically, if possible, or otherwise promptly sign, date, and return the BLUE proxy card in the postage-paid envelope provided.

    If you have any questions or require any assistance in voting your shares, please contact Brookdale’s proxy solicitor, Innisfree M&A Incorporated, at+ 1 (877) 750-5838 (toll-free from the U.S. and Canada) or +1 (412) 232-3651 (from other countries).

    ABOUT BROOKDALE SENIOR LIVING
    Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. With 647 communities across 41 states and the ability to serve approximately 58,000 residents as of March 31, 2025, Brookdale is committed to its mission of enriching the lives of seniors through compassionate care, clinical expertise, and exceptional service. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities, offering tailored solutions that help empower seniors to live with dignity, connection, and purpose. Leveraging deep expertise in healthcare, hospitality, and real estate, Brookdale creates opportunities for wellness, personal growth, and meaningful relationships in settings that feel like home. Guided by its four cornerstones of passion, courage, partnership, and trust, Brookdale is committed to delivering exceptional value and redefining senior living for a brighter, healthier future. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook at facebook.com/brookdaleseniorliving or on YouTube at youtube.com/BrookdaleLiving.

    FORWARD-LOOKING STATEMENTS
    Certain statements in this communication may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical statements of fact and those regarding the Company’s intent, belief, or expectations. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “may,” “will,” “should,” “could,” “would,” “on track,” “potential,” “intend,” “enable,” “expect,” “endeavor,” “seek,” “anticipate,” “estimate,” “executing,” “believe,” “poised,” “positioned,” “project,” “predict,” “continue,” “plan,”
    4




    “target,” or other similar words or expressions, and include statements regarding the focus of the Board of Directors and management of the Company, the execution and advancement of the Company’s strategy, the Company’s CEO search process, the Company’s ability to continue to successfully execute on key initiatives, deliver positive financial and operational performance and drive enhanced shareholder value. These forward-looking statements are based on certain assumptions and expectations, and the Company’s ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Although the Company believes that expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that its assumptions or expectations will be attained and actual results and performance could differ materially from those projected. Factors which could have a material adverse effect on the Company’s operations and future prospects or which could cause events or circumstances to differ from the forward-looking statements include, but are not limited to, events which adversely affect the ability of seniors to afford resident fees, including downturns in the economy, housing market, consumer confidence, or the equity markets and unemployment among resident family members; the effects of senior housing construction and development, lower industry occupancy, and increased competition; conditions of housing markets, regulatory changes, acts of nature, and the effects of climate change in geographic areas where the Company is concentrated; terminations of the Company’s resident agreements and vacancies in the living spaces it leases; changes in reimbursement rates, methods, or timing under governmental reimbursement programs including the Medicare and Medicaid programs; failure to maintain the security and functionality of the Company’s information systems, to prevent a cybersecurity attack or breach, or to comply with applicable privacy and consumer protection laws, including HIPAA; the Company’s ability to complete its capital expenditures in accordance with its plans; the Company’s ability to identify and pursue development, investment, and acquisition opportunities and its ability to successfully integrate acquisitions; competition for the acquisition of assets; the Company’s ability to complete pending or expected disposition, acquisition, or other transactions on agreed upon terms or at all, including in respect of the satisfaction of closing conditions, the risk that regulatory approvals are not obtained or are subject to unanticipated conditions, and uncertainties as to the timing of closing, and the Company’s ability to identify and pursue any such opportunities in the future; risks related to the implementation of the Company’s strategy, including initiatives undertaken to execute on the Company’s strategic priorities and their effect on its results; any resurgence or variants of the COVID-19 pandemic; limits on the Company’s ability to use net operating loss carryovers to reduce future tax payments; delays in obtaining regulatory approvals; the risks associated with tariffs and the uncertain duration of trade conflicts; disruptions in the financial markets or decreases in the appraised values or performance of the Company’s communities that affect the Company’s ability to obtain financing or extend or refinance debt as it matures and the Company’s financing costs; the Company’s ability to generate sufficient cash flow to cover required interest, principal, and long-term lease payments and to fund its planned capital projects; the effect of any non-compliance with any of the Company’s debt or lease agreements (including the financial or other covenants contained therein), including the risk of lenders or lessors declaring a cross default in the event of the Company’s non-compliance with any such agreements and the risk of loss of the Company’s property securing leases and indebtedness due to any resulting lease terminations and foreclosure actions; the inability to renew, restructure, or extend leases, or exercise purchase options at or prior to the end of any existing lease term; the effect of the Company’s indebtedness and long-term leases on the Company’s liquidity and its ability to operate its business; increases in market interest rates that increase the costs of the Company’s debt obligations; the Company’s ability to obtain additional capital on terms acceptable to it; departures of key officers and potential disruption caused by changes in management; increased competition for, or a shortage of, associates, wage pressures resulting from increased competition, low unemployment levels, minimum wage increases and changes in overtime laws, and union activity; environmental contamination at any of
    5




    the Company’s communities; failure to comply with existing environmental laws; an adverse determination or resolution of complaints filed against the Company, including putative class action complaints; negative publicity with respect to any lawsuits, claims, or other legal or regulatory proceedings; costs to respond to, and adverse determinations resulting from, government inquiries, reviews, audits, and investigations; the cost and difficulty of complying with increasing and evolving regulation, including new disclosure obligations; changes in, or its failure to comply with, employment-related laws and regulations; the risks associated with current global economic conditions and general economic factors on the Company and the Company’s business partners such as inflation, commodity costs, fuel and other energy costs, competition in the labor market, costs of salaries, wages, benefits, and insurance, interest rates, tax rates, tariffs, geopolitical tensions or conflicts, and uncertainty surrounding a new presidential administration, the impact of seasonal contagious illness or other contagious disease in the markets in which the Company operates; actions of activist stockholders, including as a result of the current proxy contest and any potential change of control of the Company or the Board; as well as other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission (“SEC”), including those set forth in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in such SEC filings. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect management’s views as of the date of this communication. The Company cannot guarantee future results, levels of activity, performance or achievements, and, except as required by law, it expressly disclaims any obligation to release publicly any updates or revisions to any forward-looking statements contained in this communication to reflect any change in the Company’s expectations with regard thereto or change in events, conditions, or circumstances on which any statement is based.

    CONTACTS

    [email protected]

    Tim Lynch / Leigh Parrish
    Joele Frank, Wilkinson Brimmer Katcher
    (212) 355-4449


    6


    Get the next $BKD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BKD

    DatePrice TargetRatingAnalyst
    4/1/2025$7.00Equal Weight
    Barclays
    10/16/2024$8.00Buy
    Jefferies
    10/7/2024$7.75 → $6.00Neutral → Underperform
    BofA Securities
    6/28/2024$7.50Outperform
    Macquarie
    12/15/2023$3.95 → $6.00Underperform → Neutral
    BofA Securities
    11/17/2023$7.00 → $9.00Sector Perform → Outperform
    RBC Capital Mkts
    1/17/2023$5.00 → $4.00Buy → Hold
    Stifel
    8/9/2021$7.00 → $8.00Sector Perform
    RBC Capital
    More analyst ratings

    $BKD
    SEC Filings

    See more
    • Amendment: Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update

      8-K/A - Brookdale Senior Living Inc. (0001332349) (Filer)

      7/15/25 5:10:55 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Brookdale Senior Living Inc. (0001332349) (Filer)

      7/15/25 5:00:50 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form 144 filed by Brookdale Senior Living Inc.

      144 - Brookdale Senior Living Inc. (0001332349) (Subject)

      7/10/25 3:23:25 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Brookdale Senior Living with a new price target

      Barclays initiated coverage of Brookdale Senior Living with a rating of Equal Weight and set a new price target of $7.00

      4/1/25 7:41:49 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Jefferies initiated coverage on Brookdale Senior Living with a new price target

      Jefferies initiated coverage of Brookdale Senior Living with a rating of Buy and set a new price target of $8.00

      10/16/24 7:19:46 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Senior Living downgraded by BofA Securities with a new price target

      BofA Securities downgraded Brookdale Senior Living from Neutral to Underperform and set a new price target of $6.00 from $7.75 previously

      10/7/24 7:42:01 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Former Officer Hicks George T returned 67,970 shares to the company, decreasing direct ownership by 18% to 314,631 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/22/25 4:20:59 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Director Wielansky Lee S sold $68,235 worth of shares (10,000 units at $6.82), decreasing direct ownership by 4% to 223,836 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/20/25 4:27:07 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Hausman Joshua

      3 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/2/25 4:59:17 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Hicks George T bought $50,307 worth of shares (9,140 units at $5.50), increasing direct ownership by 3% to 351,883 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      3/6/24 4:27:18 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Bumstead Frank M bought $5,360 worth of shares (1,000 units at $5.36), increasing direct ownership by 0.20% to 500,052 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      2/23/24 4:28:41 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

      7/23/25 6:45:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Comments on Results of Brookdale Senior Living Inc. Annual Meeting of Stockholders

      Ortelius' Public Campaign Has Driven Meaningful Change at Brookdale, Including the Dismissal of the Former CEO Ortelius Remains Committed to Holding the Board and Management Accountable for Performance and Actions to Maximize Value for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following statement in connection with its public campaign for change at Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), and the Company's Annual Meeting of Stockholders, which was held on July 11, 2025. Peter DeSorcy, Managing Member of Ortelius, said: "Ortelius' campaign served as an important catalyst for change at Brookdale, meaningfully impacting the Compan

      7/16/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Reports June 2025 Occupancy

      NASHVILLE, Tenn., July 8, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) reported today its consolidated occupancy for June 2025.  June 2025 Observations: June consolidated occupancy results:Weighted average occupancy of 80.5% increased 230 basis points year-over-year and 50 basis points sequentially, reflecting occupancy acceleration during the quarter, which was driven both by higher move-ins and favorable move-out activity both year-over-year and sequentially.Month end consolidated occupancy was 82.2%, increasing 70 basis points sequentially and demonstrating continued strong demand and sales execution.June same community occupancy results:Weighted average occupancy of 81.1

      7/8/25 7:15:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Leadership Updates

    Live Leadership Updates

    See more
    • Ortelius Issues Final Call to Action for Brookdale Senior Living Inc. Stockholders and Encourages a Vote for Urgent Change

      Three Independent Proxy Advisors Recommend Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround and End Years of Underperformance at Brookdale Vote FOR Ortelius' Nominees on the WHITE Proxy Card to Restore Accountability at Brookdale, and Immediately Begin the Process of Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), encouraging stockholders who have not yet voted to consider the current Board's abysmal performance, defensive tactics, dearth of responsibility, and questionable decision-making abilities. In i

      7/7/25 7:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

      Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

      7/3/25 8:00:00 AM ET
      $BKD
      $GMRE
      $NTST
      $OHI
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Glass Lewis Recommends Stockholders Vote for Change at Brookdale Senior Living Inc.

      Third Independent Proxy Advisor Confirms the Persuasive Case to Bolster Key Competencies on the Brookdale Board and Recommends Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround Glass Lewis Identifies Governance Challenges at Brookdale Including the Persistent Lack of Accountability for Legacy Directors who have Overseen Poor Performance Furthering the Need for Board Renewal Ortelius Urges Brookdale Stockholders to Vote FOR all Six of Ortelius' Nominees on the WHITE Proxy Card Ortelius Advisors, L.P. ("Ortelius") today announced that a third leading independent proxy advisory firm, Glass, Lewis & Co. ("Glass Lewis"), has recommended that stockholders vote FOR th

      7/1/25 4:30:00 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      11/14/24 4:43:24 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      11/14/24 4:17:59 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Brookdale Senior Living Inc. (Amendment)

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      2/14/24 4:46:08 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Financials

    Live finance-specific insights

    See more
    • Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

      7/23/25 6:45:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Reaffirms Strategy to Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

      The Brookdale Board's Ongoing Missteps, Shortcomings, and Strategic Failures are Palpable, and Jeopardize the Company's Viability Contrary to the Current Board's Assertions, Ortelius' Strategy is Materially Different from the Company's Current Plans Ortelius' Nominees Would Restore Accountability at Brookdale, and Immediately Begin the Process of Substantial Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD)("Brookdale" or the "Company"), which further outlines that the judgement, execution, and decision-making abilities of Brookdale's current Board of Directors

      6/16/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Outlines Pathways to Build and Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

      Issues Letter to Stockholders that Identifies Multiple Paths to Value Creation for Brookdale Departure of Long Time CEO Cindy Baier in the Face of Ortelius' Campaign Just the First Step in Holding Board Accountable We Believe Ortelius' Nominees have the Skills and Experience Necessary to Oversee the Execution of Its Strategic Plan to Drive Real Change for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: April 24, 2025 Fellow Brookdale Senior Living Stockholders, Over the past seven years, investors in Brookdale Senior Living Inc. ("Brookdale" or the "Compa

      4/24/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care